Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Dani Oh

Claude AI Raises New Safety Questions as It Autonomously Designs Lab-Validated Protein Binders

Anthropic's Claude models generated protein binders that were later validated in laboratory tests, but the experiment did not demonstrate drug discovery (Credit: National Cancer Institute/Unsplash)

Claude AI designed 1,320 protein binders and sent them into an automated lab pipeline, where 354 were confirmed to bind their intended targets, raising fresh questions about how far AI can now go on its own in biological design.

The work, led by Adaptyv Bio using Anthropic's Claude models, effectively showed an AI system assembling and running much of a protein-design workflow, with humans and lab robots handling only the physical experiments.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.